Exelixis tops bottom and topline targets for Q4, stock rises
Exelixis (EXEL) reported Q4 earnings of 37 cents per share and revenue of $228.6 million that beat analysts’ views. Analysts...
Health Care
Gilead’s credibility takes a hit on massive NASH-drug failure, rivals jump
Shares of Gilead Sciences (GILD) have tumbled 20% in the past 52 weeks on numerous reasons including weaker-than-expected quarterly results...
Q3 Earnings Preview: Canopy Growth likely to continue its recent bullish momentum
Canopy Growth (TSX: WEED, NYSE: CGC) will release its financial results for the third fiscal quarter of 2019 after the...
Key comments from Aurora Cannabis (ACB) Q2 2019 earnings conference call
Aurora Cannabis (ACB) on Monday reported a loss of C$238 million in the second quarter of 2019, compared to a...
Earnings preview: Quest Diagnostics’ Q4 results could benefit from M&A activity
Quest Diagnostics (DGX) has been pursuing strategic buyouts to tackle the slowdown in revenue growth in recent quarters, marked by...
Aurora Cannabis reports a loss of C$238 million for Q2
After a long delay, Aurora Cannabis (ACB) reported its second quarter 2019 results. The company reported a loss of C$238 million...
Four cheap biotech stocks to buy
In the current environment, investment in the biotech stocks could be a risky recommendation for the investors. Despite its erratic...
Tilray (TLRY) is reporting Q4 earnings results on March 18. What you need to know
Canadian cannabis giant Tilray (TLRY) is scheduled to report fourth-quarter earnings results on Monday, March 18. Analysts expect the company,...
Earnings Preview: Positive sentiment around Teva
Teva Pharmaceutical Industries Ltd. (TEVA) is scheduled to report fourth-quarter 2018 earnings results on Wednesday, February 13, before market open....
Aurora Cannabis Q2 Earnings: Will the shopping spree continue?
Marijuana giant Aurora Cannabis (ACB) is scheduled to report its Q2 earnings on Monday after the bell. Last month, the...
IPO update: Two healthcare unicorns went public this week
We had earlier reported on why 2018 was the year of healthcare IPOs. It seems the trend is continuing into...
ImmunoGen reports Q4 loss; stock gains as results beat estimates
Biotechnology firm ImmunoGen Inc. (IMGN) reported a wider net loss for the fourth quarter, hurt by a sharp fall in...
ImmunoGen Q4 Earnings Preview: All eyes on FORWARD trial update
ImmunoGen (NASDAQ: IMGN) is slated to report its fourth quarter 2018 results tomorrow before the bell. The most anticipated update...
Cardinal Health stock surges above 6% on Q2 earnings beat
Cardinal Health (NYSE: CAH) reported better-than-expected Q2 results primarily driven by better performance from the Pharmaceutical division. The company’s stock...
Regeneron Q4 profit soars 371%, beats estimates
Regeneron Pharmaceuticals Inc. (REGN) reported a 371% jump in earnings for the fourth quarter helped by higher product sales and...
Boston Scientific Q4 earnings beat on strong sales growth; stock moves up
Broad-based sales growth, marked by a double-digit increase in emerging markets, lifted Boston Scientific’s (BSX) fourth-quarter earnings, which surpassed the...
Humana’s stock gains as Q4 results top expectations
Humana Inc. (HUM) topped analysts’ expectations on revenue and earnings for the fourth quarter of 2018. Shares inched up slightly...
Eli Lilly Q4 profit misses estimates, cuts 2019 outlook
Eli Lilly and Company (LLY) swung to a profit in the fourth quarter from a loss last year, helped by...
Earnings: Array BioPharma delivers strong Q2 results, investors cheer
Array BioPharma (ARRY) reported 44% jump in second-quarter revenue to $82.5 million, driven by higher product sales and recognition of...
Gilead Sciences swings to profit in Q4, but misses estimates
Gilead Sciences (GILD) swung to a profit in the fourth quarter from a loss last year, helped by a plunge...
Earnings preview: Cardiovascular to drive Boston Scientific Q4 results
Boston Scientific Corporation (BSX) is set to report its fourth-quarter earnings results on Wednesday before the bell. The medical device...